Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Brand-name drug

Rybelsus price, strengths & recalls

Brand of semaglutide (generic)

Pharmacies pay $995.67 for 30 tablets of Rybelsus 14 mg tablet this week, and from $995.67 to $995.84 across its 3 priced strengths and forms. It is in shortage (being discontinued). It has 54 recalls on record, none ongoing. Its official label last changed on August 19, 2026.

Being discontinuedMedicare price 2027Brand
Pharmacies pay$995.67for 30 tablets of 14 mg tabletNo change in 4 weeks
Fair cash price
$1,155.52
Strengths
3
Makers
1
Updated
Nov 11

Rybelsus price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
3 mg tablet Brand$33.19$995.70 / 30 tabletsNo change+3.1%
7 mg tablet Brand$33.19$995.84 / 30 tabletsNo change+3.1%
14 mg tablet Brand$33.19$995.67 / 30 tabletsNo change+3.1%

The lowest cost per tablet is 14 mg tablet at $33.19. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.

Rybelsus vs generic semaglutide

There is no generic version of Rybelsus on the market yet. Its last listed patent or exclusivity runs to February 1, 2039 - generics often follow, though court cases and settlements can move the date either way.

GenericSemaglutide prices

Medicare negotiated price

$959.00$274.00-71%

Medicare negotiated a maximum fair price of $274.00 for a 30-day supply of Ozempic / Rybelsus / Wegovy, against a 2024 list price of $959.00. It takes effect on January 1, 2027.

What this means for patients

  • The negotiated price is what Medicare Part D plans pay for the drug - not your price at the counter.
  • What you pay depends on your plan's copay or coinsurance and where you are in the year. Coinsurance (a percentage) falls with the price; a flat copay may not change at all.
  • Out-of-pocket costs for Part D drugs are capped each year ($2,100 in 2026), whatever the drug.
  • If you don't have Medicare, the negotiated price doesn't apply to you - check the fair cash price above instead.

CMS counts Ozempic, Rybelsus and Wegovy as one drug because all three contain semaglutide.

Every Medicare negotiated price

Supply status: shortages & recalls

In shortage3 products are short or being discontinued
12 ongoing recalls54 recalls on record, latest Jun 2, 2021

Shortages

  • Rybelsus, Tablet, 7 mg (NDC 0169-4307-30)Novo Nordisk, Inc. · Being discontinued Jun 4, 2026 · Updated Jun 4, 2026Discontinuation of the manufacture of the drug. These products will be replaced by Ozempic (semaglutide) tablets.
  • Rybelsus, Tablet, 3 mg (NDC 0169-4303-30)Novo Nordisk, Inc. · Being discontinued Jun 4, 2026 · Updated Jun 4, 2026Discontinuation of the manufacture of the drug. These products will be replaced by Ozempic (semaglutide) tablets.
  • Rybelsus, Tablet, 14 mg (NDC 0169-4314-30)Novo Nordisk, Inc. · Being discontinued Jun 4, 2026 · Updated Jun 4, 2026Discontinuation of the manufacture of the drug. These products will be replaced by Ozempic (semaglutide) tablets.

In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.

Recalls

Showing the 6 most relevant of 54 - all recalls.

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for rybelsus? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedAugust 19, 2026
Version14 of 15
EffectiveJan 30, 2026
Read the label

These highlights do not include all the information needed to use RYBELSUS® and OZEMPIC® tablets safely and effectively. See full prescribing information for RYBELSUS and OZEMPIC tablets.RYBELSUS (semaglutide) tablets, for oral useOZEMPIC (semaglutide) tablets, for oral useInitial U.S. Approval: 2017

This drug has a boxed warning

WARNING: RISK OF THYROID C-CELL TUMORS

•

In rodents, semaglutide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures. It is unknown whether RYBELSUS and OZEMPIC tablets cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as human relevance of semaglutide-induced rodent thyroid C-cell tumors has not been determined [see Warnings and Precautions (5.1), Nonclinical Toxicology (13.1)].

•

RYBELSUS and OZEMPIC tablets are contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) [see Contraindications (4)]. Counsel patients regarding the potential risk for MTC with the use of RYBELSUS or OZEMPIC tablets and inform them of symptoms of thyroid tumors (e.g., a mass in the neck, dysphagia, dyspnea, persistent hoarseness). Routine monitoring of serum calcitonin or using thyroid ultrasound is of uncertain value for early detection of MTC in patients treated with RYBELSUS or OZEMPIC tablets [see Contraindications (4), Warnings and Precautions (5.1)].

WARNING: RISK OF THYROID C-CELL TUMORS

See full prescribing information for complete boxed warning.

•

In rodents, semaglutide causes thyroid C-cell tumors. It is unknown whether RYBELSUS and OZEMPIC tablets cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as the human relevance of semaglutide-induced rodent thyroid C-cell tumors has not been determined (5.1, 13.1).

•

RYBELSUS and OZEMPIC tablets are contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Counsel patients regarding the potential risk of MTC and symptoms of thyroid tumors (4, 5.1).

Recent major changes (as listed on the label)

Indications and Usage (1) ................................................10/2025

Dosage and Administration (2)...........................................12/2025

Warnings and Precautions

Acute Pancreatitis (5.2)...............................................10/2025

Acute Kidney Injury Due to Volume Depletion (5.5) ...........10/2025

Severe Gastrointestinal Adverse Reactions (5.6) .................10/2025

Acute Gallbladder Disease (5.8).....................................10/2025

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA213051 · Novo
First approved
September 20, 2019 (7 years ago)
Latest approved change
January 30, 2026
Approved label
PDF, Jul 31, 2026
Generic makers
None on the market
Last patent listed
February 1, 2039
Exclusivity ends
October 17, 2028

Patent dates are what the maker lists with FDA. Generic launch dates are often set by court rulings or settlements instead. Upcoming generics.

Rybelsus questions

How much does rybelsus cost without insurance?

Pharmacies pay about $995.67 for 30 tablets of rybelsus 14 mg tablet ($33.19 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $1,155.52. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is there a generic for Rybelsus?

Yes: semaglutide. Compare semaglutide prices.

Is rybelsus in shortage?

Yes. 3 products are listed as in shortage or being discontinued (being discontinued). See which ones.

Has rybelsus been recalled?

54 recalls on record, none ongoing. Recalls name specific lots - check yours.

When did the rybelsus label last change?

The official label was last updated on August 19, 2026 (version 14). See what changed.

Does Medicare have a negotiated price for Rybelsus?

Yes: $274.00 for a 30-day supply of Ozempic / Rybelsus / Wegovy, from January 1, 2027. What you pay still depends on your plan.

Talk about rybelsus

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.